|
Market Closed -
Nasdaq
01:27:30 15/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 213.38 USD | -0.14% |
|
+0.30% | +16.83% |
| 12/08 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 12/08 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
| Market Cap | 1.12TCr 966.67Cr 908.37Cr 826.12Cr 1.55TCr 1,07000Cr 1.58TCr 11TCr 4.16TCr 54TCr 4.2TCr 4.11TCr 1,78100Cr | P/E 2026 * |
-80.2x | P/E 2027 * | 45.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.1TCr 953.16Cr 895.67Cr 814.57Cr 1.53TCr 1,05500Cr 1.56TCr 10TCr 4.1TCr 53TCr 4.14TCr 4.05TCr 1,75600Cr | EV / Sales 2026 * |
11.4x | EV / Sales 2027 * | 6.89x |
| Free-Float |
84.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Axsome Therapeutics, Inc.
| 1 day | -0.14% | ||
| 1 week | +0.30% | ||
| Current month | -2.12% | ||
| 1 month | -10.17% | ||
| 3 months | -6.30% | ||
| 6 months | +17.75% | ||
| Current year | +16.83% |
| 1 week | 208.95 |  | 223.4 |
| 1 month | 206.94 | | 245.5 |
| Current year | 152.28 | | 260.19 |
| 1 year | 109.4 | | 260.19 |
| 3 years | 55.02 | | 260.19 |
| 5 years | 19.38 | | 260.19 |
| 10 years | 1.94 | | 260.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 12/01/2012 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 16/05/2018 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 12/01/2012 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 01/12/2014 |
Mark Coleman
BRD | Director/Board Member | 58 | 01/12/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/08/26 | Fiscal year | Chief Executive Officer | 13,980 | 0.0272% | ||
| 01/07/26 | Fiscal year | Chief Executive Officer | 1,48,998 | 0.2895% | ||
| 05/06/26 | Free | Director | 1,721 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | +0.30% | +95.37% | +199.01% | 1.12TCr | |
| -0.31% | +2.44% | +38.43% | -0.30% | 8.02TCr | |
| -1.02% | -0.51% | -2.54% | +26.80% | 5.06TCr | |
| -3.10% | -4.84% | +10.29% | +158.34% | 4.69TCr | |
| -0.74% | +3.26% | -49.51% | -49.96% | 4.63TCr | |
| -0.39% | +0.91% | +51.39% | -22.35% | 3.1TCr | |
| -0.52% | +7.01% | +125.98% | -34.32% | 2.53TCr | |
| -0.30% | -0.33% | +38.24% | +83.70% | 2.44TCr | |
| -1.42% | -1.11% | -3.79% | +190.40% | 2.08TCr | |
| -1.83% | -2.82% | +60.85% | +107.54% | 1.61TCr | |
| Average | -0.98% | +1.47% | +36.47% | +65.89% | 3.53TCr | |
| Weighted average by Cap. | -0.99% | +1.15% | +25.00% | +42.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 97Cr 84Cr 79Cr 72Cr 134.75Cr 9.29TCr 136.98Cr 923.44Cr 361.06Cr 4.65TCr 364.58Cr 356.67Cr 15TCr | 156.21Cr 134.92Cr 126.78Cr 115.3Cr 216.78Cr 15TCr 220.36Cr 1.49TCr 580.84Cr 7.48TCr 586.51Cr 573.77Cr 25TCr |
| Net income | -14Cr -12Cr -11Cr -10Cr -19Cr -1.34TCr -20Cr -132.78Cr -52Cr -668.57Cr -52Cr -51Cr -2.22TCr | 26Cr 22Cr 21Cr 19Cr 36Cr 2.47TCr 36Cr 246.03Cr 96Cr 1.24TCr 97Cr 95Cr 4.12TCr |
| Net Debt | -16Cr -14Cr -13Cr -12Cr -22Cr -1.5TCr -22Cr -148.8Cr -58Cr -749.27Cr -59Cr -57Cr -2.49TCr | -44Cr -38Cr -35Cr -32Cr -60Cr -4.16TCr -61Cr -413.99Cr -161.87Cr -2.08TCr -163.45Cr -159.9Cr -6.93TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | $213.67 | -0.00% | 4,76,327 |
| 13/26/13 | $213.68 | -0.46% | 7,05,315 |
| 12/26/12 | $214.66 | -0.51% | 12,40,601 |
| 11/26/11 | $215.77 | -2.32% | 8,34,377 |
| 10/26/10 | $220.89 | +3.83% | 13,98,625 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
Select your edition
All financial news and data tailored to specific country editions
